Mercaptopurine delayed-release - Teva

Drug Profile

Mercaptopurine delayed-release - Teva

Alternative Names: Delayed Release 6 mercaptopurine - Teva; Delayed Release 6 MP - Teva; DR 6MP

Latest Information Update: 15 Apr 2013

Price : $50

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Antineoplastics; Purines; Small molecules; Sulfhydryl compounds
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Crohn's disease

Most Recent Events

  • 30 May 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top